OFFICIAL PUBLICATION OF

by its subsidiary APPco

Apotex decision a warning bell

Megan Haggan 14/04/2016

Apotex’ decision to pull two of its PBS-listed products should ring an alarm for the health and pharmaceuticals sector, says Belinda Wood, CEO of the Generic and Biosimilar Medicines Association. Yesterday Apotex announced that it will be ceasing supply of two PBS listed prescription products from its portfolio: paracetamol/codeine tablets 500mg/30mg blister pack 20; and

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Category killer’ CWH has scope for growth

You're under no obligation to provide advice on that product. In fact, you probably shouldn't because you have not screened…

Bart Pharm

Did wave of protest fail to break?

Are they? STILL SOLICITING BRIBES!

D vL

Did wave of protest fail to break?

Coles and Woolies have been good for competition? Have you not followed the Senate inquiry into the supermarkets and how…

Bart Pharm

Pharmacy needs retention plan

But as an owner you would do quite well

Hery Briskin

Apotex decision a warning bell

Previous Queensland pharmacist vaccination now permanent

Next Aussies encouraged to vaccinate and help kids in India

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous Queensland pharmacist vaccination now permanent

Next Aussies encouraged to vaccinate and help kids in India

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.